DK19579A - Fremgangsmaade til fremstilling af spirothienohydantoinderivater - Google Patents
Fremgangsmaade til fremstilling af spirothienohydantoinderivaterInfo
- Publication number
- DK19579A DK19579A DK19579A DK19579A DK19579A DK 19579 A DK19579 A DK 19579A DK 19579 A DK19579 A DK 19579A DK 19579 A DK19579 A DK 19579A DK 19579 A DK19579 A DK 19579A
- Authority
- DK
- Denmark
- Prior art keywords
- spirothienh
- interventives
- hydanto
- preparing
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87054278 | 1978-01-18 | ||
| US05/870,542 US4127665A (en) | 1978-01-18 | 1978-01-18 | Thienohydantoin derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK19579A true DK19579A (da) | 1979-07-19 |
| DK151260B DK151260B (da) | 1987-11-16 |
| DK151260C DK151260C (da) | 1988-05-09 |
Family
ID=25355609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK019579A DK151260C (da) | 1978-01-18 | 1979-01-17 | Analogifremgangsmaade til fremstilling af spiro-thienohydantoinderivater. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4127665A (da) |
| JP (1) | JPS54109975A (da) |
| BE (1) | BE873500A (da) |
| DE (1) | DE2901477C2 (da) |
| DK (1) | DK151260C (da) |
| FR (1) | FR2415112A1 (da) |
| GB (1) | GB2012759B (da) |
| IE (1) | IE47726B1 (da) |
| IT (1) | IT1110007B (da) |
| LU (1) | LU80795A1 (da) |
| NL (1) | NL176459B (da) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4147797A (en) * | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
| US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
| US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
| US4210667A (en) * | 1979-04-19 | 1980-07-01 | Pfizer Inc. | Pharmaceutical preparations containing coumarin carboxylic acid derivatives |
| AU532110B2 (en) * | 1979-11-13 | 1983-09-15 | Ici Ltd. | Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives |
| DE3261684D1 (en) * | 1981-05-12 | 1985-02-07 | Ici Plc | Pyrrole derivatives |
| US4464385A (en) * | 1982-04-15 | 1984-08-07 | Alcon Laboratories, Inc. | Treatment of diabetic complications with hydantoins |
| US4540700A (en) * | 1982-04-15 | 1985-09-10 | Alcon Laboratories, Inc. | Treatment of diabetic complications with certain spiro-imidazolidine-diones |
| US4438272A (en) | 1982-04-15 | 1984-03-20 | Alcon Laboratories, Inc. | Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones |
| US4436745A (en) | 1982-04-15 | 1984-03-13 | Alcon Laboratories, Inc. | Method of inhibiting aldose reductase activity |
| US4864028A (en) * | 1983-09-14 | 1989-09-05 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives |
| US5153211A (en) * | 1983-09-14 | 1992-10-06 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
| US4537892A (en) * | 1983-09-14 | 1985-08-27 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
| US5070100A (en) * | 1983-09-14 | 1991-12-03 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives |
| WO1986000807A1 (en) * | 1984-07-20 | 1986-02-13 | Pfizer Inc. | Spiro-imidazolones for treatment of diabetes complications |
| US4966911A (en) * | 1984-11-20 | 1990-10-30 | Washington Research Foundation | Immunoregulatory agents |
| US5340829A (en) * | 1984-11-20 | 1994-08-23 | Washington Research Foundation | Immunoregulatory agents |
| JP2708507B2 (ja) * | 1988-04-07 | 1998-02-04 | 株式会社三和化学研究所 | （ｄ）‐６‐フルオロ‐２，３‐ジヒドロ‐２’，５’‐ジオキソ‐スピロ［４Ｈ‐１‐ベンゾピラン‐４，４’‐イミダゾリジン］‐２‐カルボキサミド誘導体、これらの製法及び用途 |
| EP0536119A4 (en) * | 1989-02-10 | 1993-08-04 | Washington Research Foundation | Immunoregulatory agents |
| WO2011069063A2 (en) * | 2009-12-04 | 2011-06-09 | Sunovion Pharmaceuticals, Inc. | Multicyclic compounds and methods of use thereof |
| MX2019000982A (es) | 2016-07-29 | 2019-07-04 | Sunovion Pharmaceuticals Inc | Compuestos y composiciones y usos de los mismos. |
| JP7187437B2 (ja) | 2016-07-29 | 2022-12-12 | サノビオン ファーマシューティカルズ インク | 化合物および組成物ならびにそれらの使用 |
| EP3582815A1 (en) | 2017-02-16 | 2019-12-25 | Sunovion Pharmaceuticals Inc. | Methods of treating schizophrenia |
| US10780074B2 (en) | 2017-08-02 | 2020-09-22 | Sunovion Pharmaceuticals Inc. | Compounds and uses thereof |
| SG11202007823PA (en) | 2018-02-16 | 2020-09-29 | Sunovion Pharmaceuticals Inc | Salts, crystal forms, and production methods thereof |
| EP3938045A1 (en) | 2019-03-14 | 2022-01-19 | Sunovion Pharmaceuticals Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
| CA3180115A1 (en) | 2020-04-14 | 2021-10-21 | Sunovion Pharmaceuticals Inc. | (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB796069A (en) * | 1955-12-23 | 1958-06-04 | Ici Ltd | Substituted hydantoins |
| DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
| CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
-
1978
- 1978-01-18 US US05/870,542 patent/US4127665A/en not_active Expired - Lifetime
-
1979
- 1979-01-16 LU LU80795A patent/LU80795A1/xx unknown
- 1979-01-16 BE BE0/192915A patent/BE873500A/xx not_active IP Right Cessation
- 1979-01-16 DE DE2901477A patent/DE2901477C2/de not_active Expired
- 1979-01-17 GB GB791692A patent/GB2012759B/en not_active Expired
- 1979-01-17 NL NLAANVRAGE7900354,A patent/NL176459B/xx not_active IP Right Cessation
- 1979-01-17 FR FR7901155A patent/FR2415112A1/fr active Granted
- 1979-01-17 DK DK019579A patent/DK151260C/da not_active IP Right Cessation
- 1979-01-17 JP JP444379A patent/JPS54109975A/ja active Granted
- 1979-01-17 IT IT19369/79A patent/IT1110007B/it active
- 1979-01-30 IE IE88/79A patent/IE47726B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7900354A (nl) | 1979-07-20 |
| JPS54109975A (en) | 1979-08-29 |
| DK151260B (da) | 1987-11-16 |
| BE873500A (fr) | 1979-07-16 |
| IT1110007B (it) | 1985-12-23 |
| LU80795A1 (fr) | 1979-09-07 |
| IT7919369A0 (it) | 1979-01-17 |
| IE47726B1 (en) | 1984-05-30 |
| FR2415112B1 (da) | 1983-01-14 |
| NL176459B (nl) | 1984-11-16 |
| FR2415112A1 (fr) | 1979-08-17 |
| DE2901477A1 (de) | 1979-07-19 |
| GB2012759B (en) | 1982-05-26 |
| DE2901477C2 (de) | 1982-06-09 |
| US4127665A (en) | 1978-11-28 |
| IE790088L (en) | 1979-07-18 |
| JPS612067B2 (da) | 1986-01-22 |
| DK151260C (da) | 1988-05-09 |
| GB2012759A (en) | 1979-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK363179A (da) | Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater | |
| DK457779A (da) | Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater | |
| DK149023C (da) | Analogifremgangsmaade til fremstilling af tiazolidinderivater | |
| DK207279A (da) | Fremgangsmaade til fremstilling af e-vitaminpulver | |
| DK7579A (da) | Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid | |
| DK19579A (da) | Fremgangsmaade til fremstilling af spirothienohydantoinderivater | |
| DK364579A (da) | Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider | |
| DK54879A (da) | Fremgangsmaade til fremstilling af pyrimidoner | |
| DK488379A (da) | Fremgangsmaade til fremstilling af polyetherderivater | |
| DK294880A (da) | Fremgangsmaade til fremstilling af n-phosphonomethylglycin | |
| DK413780A (da) | Fremgangsmaade til fremstilling af d-6-n-propylergoliner | |
| DK152138C (da) | Fremgangsmaade til fremstilling af urokinase | |
| DK138879A (da) | Fremgangsmaade til fremstilling af lysergolderivater | |
| DK311779A (da) | Fremgangsmaade til fremstilling af spaanplader | |
| DK161198C (da) | Analogifremgangsmaade til fremstilling af substituerede omega-aroylpropionyl-l-proliner | |
| DK165687C (da) | Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner | |
| DK150479C (da) | Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin | |
| DK330279A (da) | Fremgangsmaade til fremstilling af soem | |
| DK177680A (da) | Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner | |
| DK196579A (da) | Fremgangsmaade til fremstilling af substituerede dibenzylethere | |
| DK127179A (da) | Fremgangsmaade til fremstilling af monokaryoner | |
| DK157850C (da) | Fremgangsmaade til fremstilling af 7-acylindolin-2-oner | |
| DK250679A (da) | Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin | |
| DK12879A (da) | R fremgangsmaade til fremstilling af ergopeptidalkaloidderivate | |
| DK12379A (da) | Fremgangsmaade til fremstilling af cysteinholdige peptider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |